Back to Search
RICHARD SANTEN, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1417091281IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
0101053325(VA)
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 1965
Research & Publications (20)
History of aromatase: saga of an important biological mediator and therapeutic target.
PMID 19389994·Endocr Rev·2009
6-review
Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
PMID 19250200·Ann N Y Acad Sci·2009
6-review
Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.
PMID 19138696·Steroids·2009
6-review
Assessing individual risk for breast cancer: role of oestrogens and androgens.
PMID 19128423·Breast Cancer Res·2008
8-other
Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.
PMID 18637482·Adv Exp Med Biol·2008
6-review
Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures.
PMID 18614192·Steroids·2008
8-other
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model.
PMID 17639036·Endocr Relat Cancer·2007
6-review
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.
PMID 17588628·Steroids·2007
4-observational
Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
PMID 16317288·Anticancer Drugs·2006
7-preclinical
Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells.
PMID 16258703·Breast Cancer Res Treat·2005
8-other
Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
PMID 16113100·Endocr Relat Cancer·2005
8-other
Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
PMID 16112950·Gynecol Endocrinol·2005
6-review
Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
PMID 16024245·J Steroid Biochem Mol Biol·2005
6-review
Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.
PMID 14734489·Clin Cancer Res·2004
8-other
Risk of breast cancer with progestins: critical assessment of current data.
PMID 14667988·Steroids·2003
6-review
Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
PMID 12790774·Endocr Relat Cancer·2003
6-review
To block estrogen's synthesis or action: that is the question.
PMID 12107191·J Clin Endocrinol Metab·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UVA ENDOCRINOLOGY, 415 RAY C. HUNT DRIVE
CHARLOTTESVILLE, VA 22903 - Phone
- (434) 924-1825
Quick Facts
- NPI
- 1417091281
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 61
- Publications
- 20
Are you this provider?
Claim Your Profile